Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-42165279 adjunctive therapy in major depressive disorder with anxious distress
2015-002007-29Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing JNJ-42165279 adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Change from baseline to endpoint in HDRS17 total score. Started Oct 2015; status: completed.
02
Drugs
JNJ-42165279
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2015-002007-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002007-29.